| Detailed information |
|---|
| CancerLivER ID | 2303 |
| Biomarker | CD24 |
| Biomarker Name/Symbol (given in Publication) | CD24 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | CD24 as a putative biomarker for the prediction of early recurrence and validated on independent dataset |
| Experimental Condition | Early recurrence of HCC v/s Late recurrence of HCC |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in the high-risk group |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 18381945 |
| Type of Biomarker | Prognostic |
| Pathway | humoral immune response |
| Cohort | 204 patienrs ( training dataset : 65 patients; validation dataset: 139 patients) |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Early recurrence of HCC v/s Late recurrence of HCC |
| Year of Publication | 2008 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |